Skip to main content

ORIGINAL RESEARCH article

Front. Aging Neurosci.
Sec. Alzheimer's Disease and Related Dementias
Volume 17 - 2025 | doi: 10.3389/fnagi.2025.1531628

Adolescent Binge Alcohol Exposure Accelerates Alzheimer's disease-associated Basal Forebrain Neuropathology through Proinflammatory HMGB1 Signaling

Provisionally accepted
Rachael P Fisher Rachael P Fisher Lindsay Matheny Lindsay Matheny Sarrah Ankeny Sarrah Ankeny Liya Qin Liya Qin Leon Coleman Jr Leon Coleman Jr Ryan P. Vetreno Ryan P. Vetreno *
  • University of North Carolina at Chapel Hill, Chapel Hill, United States

The final, formatted version of the article will be published soon.

    Human studies suggest that heavy alcohol use may be an etiological factor contributing to the development of Alzheimer’s disease (AD) neuropathology. Both alcohol use disorder (AUD) and AD share common underlying neuropathology, including proinflammatory high-mobility group box 1 (HMGB1)-mediated neuroimmune signaling and basal forebrain cholinergic neuron degeneration, and evidence suggests these systems are particularly sensitive to adolescent alcohol exposure. Therefore, we sought to test the hypothesis that adolescent binge alcohol exposure increases AD-associated neuropathology through proinflammatory HMGB1 signaling. In Experiment 1, AD-associated neuropathology was assessed in the post-mortem human basal forebrain of individuals with AUD and an adolescent age of drinking onset relative to age-matched moderate drinking controls (CONs). In Experiment 2, non-transgenic and 5xFAD male and female mice, which overexpress both mutant human APP and PS1, received adolescent intermittent ethanol (AIE; 5.0 g/kg, i.g. 2-days on/2-days off; postnatal day [P]30 – P55) and basal forebrain tissue collected on P100 for assessment of AD-associated neuropathology. In Experiment 3, 5xFAD female mice received AIE treatment followed by glycyrrhizic acid (150 mg/L), an HMGB1 inhibitor, in drinking water from P56 to P100, and basal forebrain tissue collected on P100 for assessment of AD-associated neuropathology. In the post-mortem human AUD basal forebrain, we report upregulation of Hmgb1 and the HMGB1 receptors Rage and Tlr4 as well as microglial activation and increased intraneuronal Aβ1-42 in association with reduced cholinergic neuron marker expression (ChAT). In the 5xFAD mouse model, AIE accelerated AD-associated induction of Hmgb1 proinflammatory neuroimmune genes, microglial activation, and reductions of ChAT+ basal forebrain cholinergic neurons in the adult female, but not male, basal forebrain. Post-AIE treatment with glycyrrhizic acid rescued the AIE-induced acceleration of AD-associated increases in proinflammatory HMGB1 neuroimmune signaling, microglial activation, and persistent reductions of basal forebrain cholinergic neurons in adult 5xFAD female mice. Together, these data suggest that adolescent binge ethanol exposure may represent an underappreciated etiological factor contributing to onset of AD-associated neuropathology in adulthood through HMGB1-mediated neuroimmune signaling.

    Keywords: Ethanol, neuroinfl ammation, Microglia, Cholinergic Neurons, HMGB1

    Received: 20 Nov 2024; Accepted: 06 Feb 2025.

    Copyright: © 2025 Fisher, Matheny, Ankeny, Qin, Coleman Jr and Vetreno. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Ryan P. Vetreno, University of North Carolina at Chapel Hill, Chapel Hill, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.